Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
Crossref DOI link: https://doi.org/10.1007/s11899-014-0229-y
Published Online: 2014-08-22
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yacoub, A.
Odenike, O.
Verstovsek, S.
License valid from 2014-08-22